key: cord-0919711-kgnpy1rr
authors: Jhanji, Megha; Rao, Chintada Nageswara; Sajish, Mathew
title: Towards resolving the enigma of the dichotomy of resveratrol: cis- and trans-resveratrol have opposite effects on TyrRS-regulated PARP1 activation
date: 2020-11-27
journal: GeroScience
DOI: 10.1007/s11357-020-00295-w
sha: dd68867cc971cb76b03b34b223cc6876af5e5c4c
doc_id: 919711
cord_uid: kgnpy1rr

Unlike widely perceived, resveratrol (RSV) decreased the average lifespan and extended only the replicative lifespan in yeast. Similarly, although not widely discussed, RSV is also known to evoke neurite degeneration, kidney toxicity, atherosclerosis, premature senescence, and genotoxicity through yet unknown mechanisms. Nevertheless, in vivo animal models of diseases and human clinical trials demonstrate inconsistent protective and beneficial effects. Therefore, the mechanism of action of RSV that elicits beneficial effects remains an enigma. In a previously published work, we demonstrated structural similarities between RSV and tyrosine amino acid. RSV acts as a tyrosine antagonist and competes with it to bind to human tyrosyl-tRNA synthetase (TyrRS). Interestingly, although both isomers of RSV bind to TyrRS, only the cis-isomer evokes a unique structural change at the active site to promote its interaction with poly-ADP-ribose polymerase 1 (PARP1), a major determinant of cellular NAD(+)-dependent stress response. However, retention of trans-RSV in the active site of TyrRS mimics its tyrosine-bound conformation that inhibits the auto-poly-ADP-ribos(PAR)ylation of PARP1. Therefore, we proposed that cis-RSV-induced TyrRS-regulated auto-PARylation of PARP1 would contribute, at least in part, to the reported health benefits of RSV through the induction of protective stress response. This observation suggested that trans-RSV would inhibit TyrRS/PARP1-mediated protective stress response and would instead elicit an opposite effect compared to cis-RSV. Interestingly, most recent studies also confirmed the conversion of trans-RSV and its metabolites to cis-RSV in the physiological context. Therefore, the finding that cis-RSV and trans-RSV induce two distinct conformations of TyrRS with opposite effects on the auto-PARylation of PARP1 provides a potential molecular basis for the observed dichotomic effects of RSV under different experimental paradigms. However, the fact that natural RSV exists as a diastereomeric mixture of its cis and trans isomers and cis-RSV is also a physiologically relevant isoform has not yet gained much scientific attention.

"juice," or "extract." Thus, "Drakshasava" means "extract from grapes.") Similarly, RSV is also considered responsible for the fundamental principle behind the "French Paradox" [2, 3] . It is produced by many different plant species, especially grapevines, pines, and legumes and therefore is abundant in peanuts, soybeans, blueberries, and pomegranates [4] . RSV is produced in plants as a protective agent in response to stressful conditions such as injury or attack by bacterial/fungal pathogens or UV exposure and believed to activate the innate defense mechanism of plants against fungal/ microbial pathogens [5] . Interestingly, Botrytis cinerea infection in grapes leads to the exclusive synthesis of RSV in the leaf epidermis and grape skins [5] [6] [7] . Since grape skins are fermented during red wine production, they contain higher amounts of RSV than white wines. RSV was first isolated in 1939 by Takaoka from Veratrum grandiflorum Loes (the root of the white hellebore) [8] . Hence, it is speculated that the name "resveratrol": was created based on its chemical structure and the source of the plant used for its isolation (a resorcinol derivative or polyphenol in resin from a Veratrum species). Despite being a protective molecule in plants, the ingestion of RSV could also evoke similar protective stress responses in animals and was widely expected to overcome stressful/harmful conditions [9] , including auto-immune disorders [10] . Unfortunately, despite being one of the widely studied small molecules, the in vivo animal models of diseases and human clinical studies using RSV brought out inconclusive results [11, 12] , indicating our understanding of the mechanism of action of natural RSV is not yet complete.

The enigma of the dichotomic and pro-aging effects of RSV Natural RSV captured widespread scientific and public interest due to its reported anti-cancer [13] and antiaging effects [14] , supported by further longevity demonstrations in other organisms [15] [16] [17] [18] . However, unlike widely perceived, RSV decreased the normal (chronological) lifespan in yeast [19] [20] [21] , and it extended only the replicative lifespan which is calculated based on the number of daughter cells an individual yeast mother cell produces before dying [14] . Moreover, the replicative lifespan effect of RSV in yeast was immediately questioned as it was not reproducible [22] indicating that the mechanism of action of the anti-and proaging effects of RSV is not yet understood. Similarly, higher doses of RSV decreased the normal lifespan in mice as well (mice died within 3-4 months) [23] and resulted in kidney toxicity in rats [24] . Consistent with the pro-aging effects of RSV [19] [20] [21] 23] , it is known to evoke toxic effects such as induction of neurite degeneration [25] , atherosclerosis [26] , premature senescence [27] [28] [29] [30] [31] [32] , genotoxicity [33] [34] [35] [36] [37] [38] , and inhibition of hippocampal neurogenesis [39] . These observations suggest that the mechanism of action of RSV that promoted longevity in other organisms [15] [16] [17] [18] is not yet completely understood. Consistently, research works using RSV showed dichotomic effects resulting in inconsistent therapeutic outcomes. For example, while RSV shows protective effects against experimental models of multiple sclerosis (MS) and autoimmune encephalomyelitis (EAE) in some studies [40] [41] [42] , it exacerbated the progression of MS and EAE in another study [43] . Similarly, RSV protects against peripheral neuropathy in some studies [44, 45] while it exacerbates the disease condition in another study [46] . Likewise, while RSV is known to protect against anxiety and depression [47] , it is also shown to exacerbate anxiety and depression [48] . Interestingly, acute RSV treatment enhanced cocaine-induced dopamine neurotransmission and behavioral responses suggesting that RSV promotes drug addiction [49, 50] . However, RSV is also shown to protect against drug addiction through an unknown mechanism [51, 52] . Consistent with the dichotomic effects discussed above, RSV protects against Wallerian degeneration [53] , but it also abolishes neuroprotection mediated through Wallerian-slow degeneration mutants [25] . Similarly, RSV acts as an antagonist on aryl hydrocarbon receptor (AhR) [54] and estrogen receptor alpha (ERα) [55] , but it also acts as an agonist of AhR [40] and ERα [56, 57] . The dichotomic effect of RSV is also observed in the induction of autophagy. While RSV stimulates autophagy [17, 27, 58] , it is also known to inhibit autophagy [59, 60] . Interestingly, although RSV inhibits nuclear factor kappa B (NF-κB) in some studies [61, 62] , RSV instead activates NF-κB in other studies [63] [64] [65] [66] . Moreover, although RSV exacerbates atherosclerosis [26] , it is also shown to prevent atherosclerosis [67, 68] . Consistently, RSV also exacerbated inflammation state and superoxide production and diminishing aortic distensibility in aged mice [69] . Likewise, RSV protects against oxidative stress in some studies [70] [71] [72] while it exacerbates oxidative stress in other studies [73, 74] . Consistently, RSV exhibits both pro-oxidant and antioxidant effects [75, 76] .

Interestingly, the pro-oxidant activity of RSV inhibits hydrogen peroxide (H 2 O 2 )-induced apoptosis [77] and evokes cardiac protection [78] and anti-tumor effects [38] . Although RSV induces premature senescence [27] [28] [29] [30] [31] [32] , RSV is also known to inhibit senescence through an unknown mechanism [79] . RSV is widely believed to enhance mitochondrial function [80] , despite being a potent inhibitor of mitochondria [81] [82] [83] [84] [85] . RSV inhibits oxidative phosphorylation (OXPHOS) activity at two sites: mitochondrial complex I and complex III of the electron transport chain [82, 83] . Consistently, RSV increases the mitochondrial H 2 O 2 production [84] and decreases ATP production [83, 85] . Therefore, RSV induces mitochondria-driven apoptosis [86] through the elevation in intracellular Ca 2+ , resulting in the collapse of the membrane potential with mitochondrial permeability transition pore (mPTP) opening and cytochrome c release into the cytosol [87] . Although RSV is known to evoke anti-tumor effects [13, [88] [89] [90] [91] , it is also known to exacerbate cancer proliferation [56, 92, 93] and shows dichotomic effects in angiogenic response as well [94, 95] . Similarly, despite being reported to evoke anti-obesity effects [96-98], intriguingly, higher doses of RSV rather had a weight-promoting effect when mice were fed with a high-fat diet [89] . Although RSV is shown to evoke anti-diabetic effects [ Consistent with the dichotomic effects of RSV, as discussed above, human clinical trials using RSV also ended up in favorable and unexpected outcomes [11, 12] [146] and obese people [97] . Consistently, most recent meta analysis also indicates that RSV improves cardiometabolic health by decreasing some risk factors (HOMA-IR, LDL-C, and T-Chol) associated with cardiovascular disease (CVD) [147, 148] and significantly reduced total cholesterol and increased gammaglutamyl transferase (GGT) concentrations in patients with metabolic syndrome (MetS) and related disorders [149] . In conclusion, along with substantial protective/ beneficial effects of low-dose RSV demonstrated in various studies, exacerbation of the disease conditions especially by higher doses of RSV is also an accompanying theme in human clinical trials. However, the molecular basis for these dichotomic effects of RSV largely remains unexplained, and these opposing effects observed upon RSV treatment remain an enigma [150] .

Low-dose beneficial effects versus high-dose detrimental effects of RSV Beyond the unexpected outcomes in multiple models of diseases, it is apparent that low doses of RSV evoke health-promoting effects and detrimental effects are generally observed only upon treatment with high doses of RSV as observed in the cases of human AD clinical trails [121, 122] . Therefore, RSV often displays a biphasic dose-response [151] with features consistent with the hormetic dose-response, a phenomenon that is characterized by low-dose stimulation and a high-dose inhibition [152] . RSV inhibits DNA type II topoisomerase [153] , and histone deacetylases (HDACs) [154] , enzymes that are critical for the maintenance of chromosomal stability [155] , and neuronal survival [156, 157] , resulting in genotoxic effects. Consistently, treatment with high-dose RSV induces DNA double-strand breaks (DSBs) [153, 158, 159] along with downregulation of DNA repair proteins [160] , while low-dose RSV rather upregulates DNA repair proteins [161, 162] . Furthermore, a lower dose of RSV significantly reduced chromosomal instability (CIN) as well as defective spindle assembly checkpoint (SAC), while higher doses of RSV significantly induced them [36] . Therefore, RSV reduces cell growth and induces apoptosis in healthy cells in a dose-dependent manner triggering biphasic effects over low to high concentrations [163, 164] . For example, low-dose RSV enhances self-renewal of stem cells through inhibition of senescence whereas higher dose RSV instead inhibits self-renewal and induces senescence [165] [166] [167] [168] through cell cycle arrest at S/G2 phase [36, 169, 170] . Hence, at a lower concentration, RSV can have a positive impact on the proliferation, survival of neuronal progenitor cells (NPCs), and rat hippocampal neurogenesis [167] , which is also consistent with its angiogenic effects at a lower dose [94] . Consistently, low-dose RSV protected against amyotrophic lateral sclerosis (ALS) [171] and Huntington's disease (HD) [172] , but a higher dose of RSV rather failed to improve motor deficits associated with the HD phenotype in a transgenic mouse model [173] . Intriguingly, pre-treatment with low-dose RSV, however, failed to reduce amyloid beta-mediated elevation of H 2 O 2 production [174] . Although RSV was identified as an anti-inflammatory compound [175, 176] , RSV modulates the inflammatory response in an ERαdependent manner [57] . At medium concentrations (10-25 μM), RSV acts as a superagonist of estradiol [177] , while at lower concentrations, RSV relatively inhibited the estradiol-driven transcription through a yet unknown mechanism [177] . Similarly, RSV binds directly to mitochondrial complex I and induces oxidative stress in aged mice in a dose-dependent manner [73] . At low doses, RSV stimulated complex I and F0/ F1 ATPase activities, whereas, at high doses, it inhibited them [73, 178] . Therefore, low concentrations of RSV trigger and high concentrations inhibit respiratory chain complexes [179] . Similarly, low doses of RSV promoted in vitro muscle regeneration and attenuated the impact of reactive oxygen species (ROS), while high doses exacerbated the reduction in plasticity and metabolism induced by oxidative stress [180] . Intriguingly, lower doses of RSV generate ROS, and higher doses of RSV act as an anti-oxidant in erythrocytes [181] and prooxidant properties of low-dose RSV inhibit caspase activation and DNA fragmentation induced by oxidative stress [182] . However, in indomethacin-induced gastric ulcers, high-dose RSV instead exacerbated ulcerative damage in mice [183] . Similarly, a low-dose RSV administration partly improved renal function in mice with kidney damage caused by a unilateral ureteral obstruction (UUO) while high dose of RSV lost its anti-fibrotic effect and exacerbated kidney fibrosis [184] . Likewise, RSV induced a dose-dependent pro-oxidant effect in hepatic stellate cells (HSC) with the highest dose of RSV inducing oxidation-related damage and drastically reducing cell viability [185, 186] . Similarly, high-dose RSV upregulated genes involved in gluconeogenesis [100] and inhibited insulin signaling [108, 187, 188] , but low-dose RSV rather downregulated gluconeogenesis [100] and improved insulin sensitivity [99, 103, 143, 145, 189, 190] .

Although approximately 75% of RSV is absorbed after oral consumption [191] , it is rapidly metabolized by the liver, intestinal tract, and gut microbiota into the sulfated and glucuronidated forms such as RSV-3'-O-β-d-glucuronide (RSV3G), RSV-4′-O-d-glucuronide ( R S V 4 G ) , a n d R S V -3 -O -s u l f a t e ( R S V 3 S ) . Interestingly, RSV is more stable in human plasma compared to rat plasma [192] , and RSV crosses the blood-brain barrier (BBB) and accumulates in the brain tissue as well [117] . Therefore, the concentrations of these RSV metabolites far exceed the concentrations of their parent compound (free RSV) in human serum [27, 193] and ocular tissues [194] . For example, human oral ingestion of low dose (5 mg) RSV daily can achieve the plasma concentrations of 0.12-0.6 μM RSV [89], and human clinical trials receiving 5-1000 mg daily dose resulted in average peak concentrations of blood levels between 0.6 and 137 μM [89, 194] . Furthermore, sustained intake of 1 g of RSV as a food supplement resulted in a concentration of 50-640 μM RSV in human colonic tissues [27] . Moreover, sulfate metabolites of RSV contribute to the in vivo activity of these metabolites by regenerating free RSV in colorectal cell lines, supporting the hypothesis that RSV metabolites potentially serve as a reservoir for the parent compound [27, 195] . These paradigm shifting studies have not only challenged the classical notion that low bioavailability of RSV is the reason for the lack of therapeutic effects in human clinical trials but have also provided a potential molecular basis for the unexpected effects of high-dose RSV in human clinical trials such as adverse gastrointestinal effects [196, 197] . The recent results from clinical trials and in vivo studies also support the hormetic response of RSV with lower doses retarding age-related cardiac dysfunction [198] , preventing cancer [89], slowing down AD symptoms [122] , and improving cardiovascular and cerebrovascular functions [23, 196] more potently than higher doses [89] .

trans-RSV is a direct activator of SIRT1 at higher micromolar concentrations Although there are many known targets for trans-RSV [199] , the most well-studied target is SIRT1 [14] . Later studies also indicated a direct link between trans-RSV and 5′ adenosine monophosphate-activated protein kinase (AMPK) and SIRT1 by showing RSV's inhibitory effect on several phosphodiesterases (PDE) that increased cyclic AMP (cAMP) levels to enhance the intracellular Ca 2+ to activate Ca 2+ /calmodulin-dependent protein kinase kinase β (CaMKKβ), which phosphorylates AMPK, finally leading to SIRT1 activation [200, 201] . Although, the attempts to modulate the activity and specificity of RSV through different targets or signaling cascades failed to reproduce the complete spectrum of its activity, [202, 203] highlighting some technical problems associated with the "Fluor-de-Lys" substrate (FdL) assay used to determine RSV-mediated SIRT1 activation [20, 22, 204, 205] , subsequent works finally concluded that trans-RSV is indeed a direct activator of SIRT1 [206] [207] [208] with a potency of RSV against SIRT1 in the FdL assay (EC 50~3 0-100 μM) [14, 207] whereas the Km value of SIRT1 for NAD + was found to be 94 ± 5 μM [203] . Finally, patients who received 500 mg/day RSV demonstrated the activation of SIRT1 in peripheral blood mononuclear cell (PBMC), suggesting that oral administration of higher doses of RSV achieve sufficient cellular concentrations to activate SIRT1 (≥ 30 μM) in humans as well [209] . This finding is also consistent with other human clinical trials that used 5-1000 mg/day RSV resulted in average peak concentrations of blood levels between 0.6 and 137 μM [89, 194] .

Intriguingly, in mammalian cells, RSV is also known to inhibit SIRT1 [14] , and this inhibitory effect of RSV on SIRT1 is required for its longevity effects in Caenorhabditis elegans [15] . Moreover, RSV decreases yeat chronological lifespan in a Sir2-dependent manner [19] . This apparent contradictory observation was termed as the "dichotomy" of RSV's action, and the mechanism remained unknown. Furthermore, later studies also demonstrated that RSV inhibits SIRT1 to mediate part of its biochemical and functional outcomes. For example, while SIRT1 activates vascular endothelial growth factor (VEGF) expression [210, 211] , treatment with RSV rather downregulates it [212, 213] . Likewise, activation of SIRT1 inhibits muscle differentiation and mitochondrial biogenesis [214] [215] [216] [217] , whereas RSV rather potentiates muscle differentiation [218, 219] and acts as an exercise mimetic [220] . Activation of SIRT1 sensitizes neurons to oxidative stress [221, 222] and inhibits neurogenesis [223] while RSV protects neurons against oxidative stress [224, 225] and enhances neurogenesis [226, 227] . Similarly, activation of SIRT1 promotes mitochondrial fission [228] , and treatment with RSV rather enhances mitochondrial fusion [229] . Similarly, although brain-specific activation of SIRT1 drives anxiety and exploratory drive [48, 230] , RSV rather protects against autistic features [231] [232] [233] [234] . Interestingly, SIRT1 activates monoamine oxidase A (MAO-A) in the brain [230] , but RSV inhibits it [235, 236] . Furthermore, RSV is known to exert metabolic benefits by increasing metabolic rate, insulin sensitivity, mitochondrial biogenesis, and physical endurance, and reduce fat accumulation in mice [80, 98, 201] . Although lower doses of RSV (≥ 25 μM) fail to inhibit PDEs [207] , RSV is also shown to upregulate the cellular levels of cyclic AMP (cAMP) though phosphodiesterases (PDEs) [201] . However, increasing cAMP levels via the Epac pathway retards the clearance of autophagy substrates and inhibits α-synuclein clearance, and enhances polyglutamine aggregation in the Parkinson's disease (PD) mouse model [237] . Intriguingly, RSV rescues mutant polyglutamine cytotoxicity [118] and alleviates motor and cognitive deficits in the A53T αsynuclein mouse model of PD [238] , whereas SIRTuin inhibition also rescues polyglutamine cytotoxicity [239] , and PD [240] and motor deficits after peripheral nerve injury [241] . Similarly, SIRT1 inhibits p53 [242] , a known anti-tumor protein, and RSV is known to exert anti-cancer effects through p53 activation [13, 243] . Although SIRT1 is essential for coronavirus replication and survival [113], RSV instead inhibits coronavirus replication [112, 113] , and the acetylation of p53 is a critical mediator of antiviral response [244] . Interestingly, RSV treatment is known to activate p300 acetyltransferase to protect against rat spinal cord affected by sciatic nerve injury [245] and is also known to activate AMPK independent of SIRT1 in neurons [246] through yet unknown mechanisms. However, RSV activates AMPK in a poly-ADP-ribose polymerase 1 (PARP1)-dependent manner [71] , which is also a potent inhibitor of SIRT1 [247] . Although the mechanism of RSV-mediated inhibition of SIRT1 [14, 15] and activations of p53 in human PBMC [209] and AMPK in neurons [246] remain an enigma, the observations mentioned above suggest that the inhibitory effects of RSV on SIRT1 [14, 15] through PARP1 activation [71] may also contribute to the observed physiological functions of RSV.

cis-RSV is present in the commercial wines RSV exists as a mixture of its diastereomeric cis (Z) and trans (E) isomers in wines [248] [249] [250] (Fig. 1a) , and both isomers are stable when protected from light for at least 6 weeks at 4°C and are not prone to oxidation within at least 48 h of exposure to air [248] . Although cis-RSV has not been detected in fresh grapes [5] [6] [7] , it is nevertheless a significant component of commercial wines from every wine-producing region of the world as well [248, 250] . This observation suggests that cis-RSV is produced during fermentation through an unknown mechanism. Wines that are high in trans-RSV tend to be also high in cis-RSV, and their concentrations may be subject to the same variables such as cultivar, climate, soil composition, and drainage characteristics, fungal pressure, and wine-making techniques [248] . In general, the absorbance of cis-RSV is lower than that of trans-RSV [250] , and the accurate quantitation of cis forms showed that the concentration of cis-RSV could sometimes be the predominant form in specific grape varietals such as Pinot noir [248, 250] .

Although cis-RSV is not well-explored, the limited amount of scientific literature shed light on its biological effects. cis-RSV inhibits both canonical and noncanonical inflammasome activation in macrophages resulting in the downregulation of caspases 1 and 4 and reduction in the secretion of the pro-inflammatory cytokine, interleukin-1β (IL-1β) [251] . Interestingly, the reduction of IL-1β secretion was more pronounced with cis-RSV pre-treatment than trans-RSV [251] . cis-RSV also scavenges intracellular reactive oxygen species (ROS) and downregulates mRNA and protein levels of NOS-2 and COX-2, resulting in the attenuation of the pro-inflammatory responses [252] . cis-RSV modulates the pro-inflammatory transcription factor, NF-κB, reducing the expression of chemokines such as monocyte chemoattractant protein-1 (MCP-1) and regulated on activation normal T cell expressed and secreted (RANTES), pro-inflammatory cytokines that attract monocyte-granulocyte cells such as M-CSF (colonystimulating factor 1), GM-CSF (colony-stimulating factor 2) and G-CSF (colony-stimulating factor 3), the cytokine tumor growth factor-beta (TGF-β), and the extracellular ligand IL-1α [253] . The methylated forms of both isomers have anti-tumorogenic properties, but the cis-RSV-derived methylated forms have a higher anti-tumor effect than the trans derivatives [254] . In contrast, for the unmodified isomers, trans-RSV has greater anti-cancer activity [255] . RSV has vasorelaxant properties, and in this aspect, both isomers showed similar effects on the reduction of intracellular calcium levels when pre-treated in vascular myocytes, although co-treatment with angiotensin II, cis-RSV showed more potent effects [256, 257] . However, when tested in mice model against angiotensin II (AngII)-mediated vascular inflammation, only the trans-isomer was found to be effective, although it is not clear whether such a result is caused by a difference in potency or is due to different mechanisms [258] . Interestingly, both cis-RSV and trans-RSV suppress the platelet aggregation induced by pro-aggregatory stimuli such as collagen, ADP, and thrombin [259, 260] . Although one study showed the potency of the cis-RSV was lower than that of the trans-RSV [260] , an earlier study showed that cis-RSV is more potent than trans-RSV to inhibity the platelet aggregation [259] . Despite early indications of the physiological effects, cis-RSV did not gain much scientific attention in terms of the number of publications ( Fig.   1b ) majorly due to the lack of commercial availability of cis-RSV in early days [261] .

Although glucuronidation of RSV is done preferentially by different UDP-glucuronosyltransferase (UGT) isoforms resulting in the formation of two glucuronides (RSV 3-O-and 4*-O-glucuronides (RSV3G and RSV4G)), interestingly, this enzymatic action can be selective with different reaction rates and occurs at a faster rate with the cis-RSV [262, 263] . For example, trans-RSV is glucoronidated by bilirubin conjugating UGT1A1 and cis-RSV is glucoronidated by the phenol conjugating UGT1A6 [262, 264] . However, both cisand trans-RSV isomers are actively glucuronidated by enzymes like UGT1A9 and 1A10 [262, 264] and the biological significance of faster glucuronidation of cis- of the total number of publications obtained by searching in Pubmed using the term "resveratrol" and "cis-resveratrol" in the titles of the publications as of 15th September, 2020 RSV remains to be evaluated. Moreover, the gastrointestinal (GI) tract contributes significantly to the first pass metabolism of these naturally occurring polyphenols [263] and cis-RSV sulfates and glucuronides (cis-RSV3G, cis-RSV4G, and cis-RSV3S) are found in higher concentrations than their trans counterparts in urine of subjects given a 250-ml single dose of red wine [265] .

trans-RSV and its metabolites convert to cis-RSV in the physiological context Interestingly, trans-RSV is known to be converted to cis-RSV in the physiological context [78, 195] , and both transand cis-RSV metabolites with a preference for cis-isomer are detected in the profiles of culture media and lysates of cells exposed to trans-RSV [195] . Importantly, in endothelial cells, when the RSV metabolites (RSV3G, RSV4G, and RSV3S) were converted back to their parent form, i.e., free RSV, they were preferentially converted to cis-RSV through a yet unknown mechanism [195] . Similarly, another recent study also showed that trans-RSV is converted to cis-RSV in the physiological context to evoke cardioprotective functions [78] . This trans to cis-RSV conversion exploits a novel thiol-dependent mechanism to activate protein kinase 1α (PKG1α) that mediates the beneficial actions of RSV. However, the thiol oxidationmediated activity of RSV is restricted to the prooxidative environment of tissues [78] . In light of the new findings that trans-RSV converts to cis-RSV and RSV reaches high micromolar concentrations in target tissues [27, 89, 194] , and RSV metabolites potentially serve as a reservoir for the parent compound [27, 195] and cis-RSV is glucuronidated faster than trans-RSV [262] [263] [264] 266] and cis-RSV sulfates and glucuronides are found in higher concentrations than their trans counterparts in humans [265] , it is critical to explore whether a combination of cisand trans-RSV would elicit synergistic or antagonistic effects in future studies.

"Moonlighting" functions of aminoacyl-tRNA synthetases (aaRSs) Aminoacyl-tRNA synthetases (aaRSs) are ancient proteins that activate L-amino acids for protein synthesis (translational function) [267] . However, during evolution, aaRSs also progressively accrued "moonlighting" functions activated under conditions of diminished protein synthesis, such as cellular stress, which is well reviewed in many recent publications [268] . These functions beyond protein synthesis (non-translational "moonlighting" functions) enable aaRSs to play critical roles in various cellular functions, including metabolic homeostasis and modulation of signal transduction pathways [268] . However, the molecular mechanisms by which aaRSs "switch ON" their "moonlighting" functions and "switch OFF" their role in protein synthesis are not very well understood. Intriguingly, knocking down aaRSs enhances longevity in C. elegans [269] but decreases it in Drosophila [270] , indicating that the non-canonical functions of aaRSs are probably significant only in higher eukaryotic organisms [271] . Each aaRS has a unique active site that precisely differentiates closely related amino acids. Interestingly, the depletion of tryptophan from the active site of tryptophanyl-tRNA synthetase (TrpRS) activates its "moonlighting" nuclear function poly-ADP-ribose-polymerase 1 (PARP1)-dependent activation of p53 [272] . Therefore, potential binding of natural amino acid analogs (metabolites, neurotransmitters, and bioactive compounds) to the active sites of aaRSs could "switch ON" their "moonlighting" functions by temporarily transforming them to catalytic nulls [273] .

cis-RSV evokes a tyrosine-free (apo) conformation in human tyrosyl-tRNA synthetase (TyrRS)

We astutely observed structural similarities between RSV and tyrosine (RSV harbors a tyrosine-like phenolic ring), and interestingly, human serum levels of Ltyrosine remain elevated under conditions that drive various metabolic dysfunctions [274] [275] [276] [277] [278] [279] [280] [281] [282] , including cancer [283, 284] . Therefore, we tested if RSV would behave as an "active site-directed inhibitor" of TyrRS and consistently found that RSV is a direct inhibitor of TyrRS catalytic activity with an inhibition constant (Ki) value of 22 μM [285] . Unlike other known biological targets of RSV (F0/F1 ATPase, ERα, SIRT3, COX-1/2) that bind to its trans-isomer [57, [286] [287] [288] , intriguingly, we found that despite using trans-RSV, we obtained the crystal structure of TyrRS bound with only the cisisomer of RSV. Therefore, TyrRS is the first and so far, the only biological target that binds to the cis-RSV. While the phenolic ring of RSV and tyrosine have the same disposition in the respective co-crystals, accommodation of the cis conformation of the dihydroxy ring of RSV forces a local structural change near the linker to the C-terminal domain of TyrRS. Based on the structural information, we proposed that RSV-triggered conformational switch in the active site of TyrRS might drive the predominant trans-RSV into a cis conformation in the physiological context. Consistently, downregulation of the cellular protein levels using siRNA against the mRNA of TyrRS mitigated the signaling effects of lowdose trans-RSV and overexpression of TyrRS was sufficient to mimic at least in part, the signaling events evoked by low dose (≥ 10 μM) trans-RSV. Therefore, we concluded that while high-dose RSV (≥ 25 μM) inhibits tyrosine-AMP formation [285] and activates SIRT1 [14, 207] , at lower concentrations of RSV (≤ 15 μM), TyrRS protein would instead facilitate the conversion of trans-RSV to cis-RSV in the physiological context, providing an underappreciated contribution of TyrRS in the biological effects of natural RSV. Moreover, a structural comparison between cis-RSV bound TyrRS, and its the tyrosine-free (apo) form demonstrated that cis-RSV mimics a tyrosine-free "apo" state of TyrRS (Fig. 2a ) and the physiological significance of this observation remains to be explored in the future. Because mutations in human TyrRS are known to cause neuropathy [289] and multi-system diseases [290] [291] [292] in a protein synthesis function-independent manner [293] , our findings suggested that RSV would be a potent modulator of the emerging "moonlighting functions" of TyrRS [46, [294] [295] [296] . In this context, it is interesting to note that inflammation drives the matrix metalloproteinase (MMP)-mediated cleavage of TyrRS [297] and RSV is a known inhibitor of MMP-2 and MMP-9 [298, 299] . Therefore, it is apparent that RSV would contribute to the systemic protein levels of TyrRS and vice versa, TyrRS would contribute to the distinct physiological outcomes of RSV, if any that are mediated through the cis and trans isomers of RSV.

Although RNA does not activate PARP1 [300] , broken DNA ends are the best-known activators of PARP1 [301] . Intriguingly, the presence of PARP1 on the broken DNA impairs efficient DNA repair [302, 303] , suggesting that eviction of PARP1 from the DNA through auto-poly-ADP-ribos(PAR)ylation is required for efficient DNA repair [304, 305] . Consistently, NAD + supplementation that enhances auto-PARylation of PARP1 facilitates PARP1-dependent DNA repair [306] . Interestingly, our work demonstrated that nuclear localization of TyrRS after either serum starvation, heat shock, or endoplasmic reticulum (ER) stress stimulates the auto-PARylation of PARP1 suggesting that eukaryotic TyrRS activates PARP1 in a DNA-independent manner [285] to facilitate TyrRSmediated DNA repair [295, 296] . Because our previous work [272] provided the structural basis of amino acids mediated inhibition of the "moonlighting" functions of aaRSs, we hypothesized that RSV that binds to TyrRS would modulate its PARP1-activating "moonlighting" function as well. Importantly, RSV was previously shown to activate PARP1-dependent protection against oxidative stress and mitochondrial dysfunctions [71] . As expected, we found that binding of cis-RSV induced conformational switch promoted the interaction of TyrRS with PARP1 and stimulated the generation of nicotinamide (NAM) and ADP-ribose (ADPR)-two potent inhibitors of SIRT1 [285] . Most significantly, RSV potentiated TyrRS-mediated auto-PARylation of PARP1 in vitro at nanomolar (nM) levels with a halfmaximal effect (EC 50 ) at roughly 10 nM, indicating that TyrRS/PARP1 complex is the biological target of RSV rather than TyrRS by itself. TyrRS-cis-RSV-PARP1driven NAD + signaling thus upregulated the expression and activation of a battery of genes, proteins, and signaling cascades that elicit a protective stress response. Most importantly, we observed significant upregulation of the acetylome of proteins, including p53, upon treatment with RSV in vitro and in vivo [285] . This observation was also consistent with RSV-mediated stimulation of the acetylation of nuclear proteins that drives autophagy [58] and CR stimulated upregulation of acetylome, including p53 [307] . However, TyrRSregulated auto-PARylation of PARP1 was lost in the presence of broken DNA [285] , suggesting that factors that induce DNA damage would abolish TyrRS/ PARP1-mediated protective stress response.

Because cis-RSV and tyrosine evoke two distinct conformations in TyrRS, treatment with a higher affinity tyrosine-adenylate analog (Tyr-SA, (5'-O-[N-(9 Ltyrosyl) sulfamoyl] adenosine)) resulted in the inhibition of cis-RSV/TyrRS-regulated auto-PARylation of PARP1 both in vitro and in vivo in mice; however, we were intrigued by the observation that despite using the commonly available trans-RSV, we obtained only the cis-isomer of RSV bound to TyrRS. To better understand it, we performed in silico modeling using the trans-RSV in the active of TyrRS. This modeling showed that the binding of trans-RSV to TyrRS did not induce any conformational change and is identical to its tyrosine-bound form [285] . This data indicated that unlike cis-RSV, retension of trans-RSV in the active site of TyrRS by higher concentrations of RSV (≥ 25 μM) would prevent the interaction of TyrRS with PARP1, leading to inhibition of PARP1 and an apparent activation of SIRT1 (due to the absence of PARP1 activation) (Fig. 2b) . Thus, our previous work for the first time suggested that the "cis" and the "trans" isomers of RSV and lower (≤ 15 μM) and higher (≥ 25 μM) doses of RSV would have opposite effects on TyrRS-regulated PARP1 activation and associated NAD + signaling [285] and indicated a potential molecular basis to resolve the "dichotomy" of RSV.

PARP1 maintains genomic stability and inflammation inhibits PARP1-mediated DNA repair PARP1 senses and responds to DNA damage [305, [308] [309] [310] , oxidative, and environmental stresses by transcriptionally activating cytoprotective and DNA repair pathways [303, 311] . To protect cells from damage, PARP1 metabolizes NAD + to nicotinamide and ADP-ribose resulting in the activation of cellular cytoprotective pathways [312] [313] [314] [315] [316] [317] [318] [319] along with rapid nuclear ATP synthesis that sustains the transcriptional upregulation of stress response genes [318, 320] . PARP1 modulates the function of the CCCTC-binding factor (CTCF) [321, 322] and feeding behavior [323] in a circadian transcription-dependent manner [311, 324] . Consistently, dopamine activates the PARP1/CTCFregulated transcriptional network to trigger morphological remodeling in astrocytes [325] . PARP1 is not only a potent modulator of SIRTuin activity [326] but also protects against genotoxic stress [315, 327, 328] , optimizes efficient DNA repair [303] , and facilitates longterm memory formation [329] [330] [331] [332] and neuronal survival under stress [333] [334] [335] . PARP1 plays a critical role in induced pluripotent stem cells (iPSCs) generation [336] and neuronal differentiation [337] . Interestingly, PARP1 knockout mice exhibited decreased neurogenesis with a concomitant increase in gliosis [338] , exacerbates diet-induced obesity [339] , induces activation. Cartoon illustration of the mechanism of isomerspecific opposite effects of cisand trans-RSV on TyrRSregulated PARP1 activation. cis-RSV facilitates TyrRS-regulated PARP1 activation, which results in the production of nicotinamide (NAM). Similarly, circadian downregulation of tyrosine in the night would also facilitate TyrRS-regulated PARP1 activation. In contrast, trans-RSV and tyrosine inhibit TyrRS-regulated PARP1 activation and the production of NAM, which is a well-known inhibitor of SIRT1. Therefore, treatment with trans-RSV or the circadian upregulation of tyrosine in the day time would also result in an apparent activation of SIRT1 due to the absence of NAM production by TyrRS-regulated PARP1 activation schizophrenia-like symptoms such as anxiety, depression, social interaction deficits, and cognitive impairments in mice [340] . Interestingly, treatment with nerve growth factor (NGF) [341, 342] and NAD + supplementation [343] activate PARP1 and protect neuron-like PC-12 cells from H 2 O 2 -mediated cell death [344, 345] , despite the accumulation of poly-ADP-ribose (PAR) [343] . Furthermore, activation of PARP1 is required for nuclear proteasome function [346, 347] that prevents the accumulation of misfolded protein aggregates, a hallmark of neurodegenerative diseases. Basal PARP1 activation is higher in the CNS of young mice [348] , and it is downregulated in AD [349] . PARylation protects against coronavirus [350] and modulates glucose metabolism [351] , and consistently, PARylation is downregulated in an age-dependent manner [352, 353] . Interestingly, naked mole-rat (NMR) has higher basal PARylation levels than the mouse [354] and is resistant to Alzheimer's disease (AD) [355] . Most significantly, inhibition of PARP1 leads to the induction of DNA damage and cytotoxicity [356, 357] and mitochondrial dysfunction [358] through the upregulation of aerobic glycolysis [359] [360] [361] , which are implicated in the etiology of various metabolic disorders and cancer. Moreover, inflammation inhibits PARP1-dependent DNA repair [359, 362, 363] and depletion of PARP1 not only triggers sustained induction of interferonstimulated genes (ISGs) [364] and senescence [365] but also exacerbates autoimmune diseases [366] [367] [368] and spontaneous cancer formation through accelerated aging [369] . In this context, it is interesting to note that inflammation also drives the cleavage of TyrRS [297] , indicating a potential role of full-length TyrRS in PARP1-mediated DNA repair [359, 362, 363] . Consistently, emerging works suggest that inhibition of PARP1 induces DNA damage-dependent pro-inflammatory response [362, 363, [370] [371] [372] and results in cancer metastasis [373] and dampens the anti-cancer immune response through the induction of programmed deathligand 1 (PD-L1) [374] . These observations suggested that activation of PARP1 not only enhances DNA repair but also triggers an anti-inflammatory signaling cascade [362] [363] [364] [365] to maintain genomic stability. Consistent with the inhibitory role of PARP1 on DNA repair [302, 303] , recently, PARP "trapping" has gained much attention in the anti-cancer treatment regimen [375] . Intriguingly, PARP1 inhibition protects neurons from toxic effects [376] [377] [378] [379] [380] [381] [382] , suggesting that PARP-dependent DNA repair and survival are context dependent. Human serum L-tyrosine level is circadian regulated and RSV has circadian effects Physiologically, human serum L-tyrosine level is modulated in a circadian manner with a peak of serum tyrosine in the morning to noon (at light) and a drop in the night (at dark) [383, 384] . Therefore, during deep sleep, humans have low serum tyrosine levels [385] . Likewise, there is a daily rhythm in the content and utilization of tyrosine in the whole mouse [386] . Interestingly, tyrosine transaminase that modulates the serum tyrosine levels [387] is regulated by vagal cholinergic nerves, which in turn, is regulated by the central nervous system (CNS) [388, 389] . Consistent with RSV being a modulator of L-tyrosine-mediated signaling [285] and tyrosine kinases [390] , RSV also restores circadian rhythm in mice [391] and upregulates circadian gene expression in fibroblasts [392, 393] . Because rhythmic histone acetylation regulates circadian gene transcription [394] , these studies are also consistent with RSV's role as a modulator of histone acetyltransferases (HDACs) [154, 207] . Intriguingly, when administered during the activity phase (at dark) in rat, RSV behaved as a potent antioxidant in the heart, the liver, and the kidney [395] , but, when administered during the rest phase (at light), RSV instead exerted pro-oxidant effects in the organs for unknown reasons [395] . Furthermore, RSV supplementation significantly increased the proportion of active-wake time, occurring mainly during the resting phase of the sleep-wake cycle (+ 163%) of adult mouse lemurs. The increase in active-wake time with RSV supplementation was accompanied by a significant reduction of both paradoxical sleep (− 95%) and slow-wave sleep (− 38%). Therefore, RSV can act as a potent modulator of sleep-wake rhythms [396, 397] . Furthermore, the nocturnal administration of RSV sharply decreased tumor frequency up to 40% and lowered tumor incidence [398] . However, daytime administration of RSV in the same N-methyl-Nnitrosourea (NMU) rat model was significantly less effective with no change in tumor incidence [398] . These observations are consistent with the recent finding that different circadian cycles in nocturnal rodents versus diurnal humans may contribute to the failure in human translational studies [399] . Therefore, an important consideration should be given to the timing of RSV administration (day vs. night) in the future clinical trials to make the best out of the circadian effects of Ltyrosine and RSV.

Calorie restriction (CR) lowers serum L-tyrosine, a biomarker for metabolic dysfunctions and aging

The most recent human metabolomic analysis demonstrated that serum L-tyrosine level is upregulated during aging [400, 401] , and its downregulation is an indicator of CR in humans [402, 403] . However, the potential mechanisms for an association between reduced serum levels of L-tyrosine and improvement in metabolic dysfunctions during CR remain unclear. Nevertheless, recent studies have confirmed the long-standing observation that elevated L-tyrosine level is a biomarker for various metabolic dysfunctions including the development of type 2 diabetes, obesity [274] [275] [276] [277] [278] [279] [280] [281] [282] , cancer [283, 284] , and memory dysfunction in human Alzheimer's disease (AD) [404, 405] . Moreover, serum L-tyrosine level has also emerged as a novel marker that links diabetes and cardiovascular disease (CVD) susceptibility [406] . Interestingly, L-tyrosine influences developmental decisions and longevity in Caenorhabditis elegans [407, 408] and potentiates the detrimental effects of oxidative stress either by decreasing glutathione and stimulating lipid and protein oxidation in rat cerebral cortex [409] or by increasing the thiobarbituric acid reactive species levels in the hippocampus and the carbonyl levels in the cerebellum, hippocampus, and striatum [410] . Moreover, chronic administration of Ltyrosine increased DNA damage frequency and damage index in the hippocampus, striatum, cerebral cortex, and blood [411, 412] . Recent studies demonstrated that chronic administration of L-tyrosine inhibited the activity of complex I, II-III, and IV in the striatum, which can be prevented by antioxidant treatment [413, 414] . Consistently, oral supplementation of L-tyrosine impairs glucose uptake and insulin secretion in rats [415] , and the capacity to detoxify excess L-tyrosine is an essential life trait for the blood-sucking arthropods [416, 417] . Quite interestingly, L-tyrosine was negatively correlated with hypothalamic transcriptional levels of Drd5, a dopamine receptor expressed in the limbic regions of the brain [418] that not only activates memory formation [419] but also evokes anti-tumor effects through autophagy induction [420] . Moreover, unlike branched-chain amino acids (BCAA) that upregulate BDNF levels [421] , the acute administration of Ltyrosine instead decreased BDNF levels in the hippocampus and striatum of rats [422] . Consistently, the administration of L-tyrosine exacerbates the cognitive decline in aged people [423] . Most significantly, a tyrosine-restricted diet stimulates human immunocompetence [424] , and CR significantly downregulates tyrosine biosynthesis and serum tyrosine levels in mice [418] as well as in humans [402, 403] . Intriguingly, similar to RSV-mediated antiatherogenic effects modulated through the focal adhesion kinase (FAK) [425] and anti-tumor effects [426, 427] , a tyrosine-free diet is also known to evoke anti-tumor effects against melanoma [428] [429] [430] in a FAK-dependent manner [431] .

cisand trans-RSV would exert opposite effects in the physiological contexts Although a significant bottleneck in tapping the therapeutic potential of RSV is the lack of a proven physiologically relevant mechanism of action, our previous work addressed some fundamental aspects of this issue and laid a foundation to bridge the gap between the observed in vitro and in vivo effects of RSV. Moreover, our discovery of TyrRS being a biologically significant and physiologically relevant target of RSV that facilitates the conversion of trans-RSV to cis-RSV suggests that the cis-isomer of RSV is also a major isomer that evokes protective stress response. Other recent studies have also confirmed the TyrRS-PARP1 signaling in mediating the protective effects of RSV [120, 229, 296, [432] [433] [434] . However, there are still critical gaps in our knowledge. The biological significance of the two distinct conformations induced by cis-and trans-RSV in TyrRS (Fig. 2) [285] has not been explored extensively. Moreover, the biological significance of cis-RSV has not gained scientific attention in terms of the number of publications (Fig. 1b) despite showing significant physiological effects, as mentioned above. In light of the new findings that RSV attains high micromolar levels in human tissues and plasma after oral ingestion [27, 89, 193, 194] and trans-RSV converts to cis-RSV in the physiological context [78, 195] , and cis-RSV has anti-inflammatory [251] [252] [253] and anti-platelet [259] and anti-cancer activities [88] and cis-RSV sulfates and glucuronides are found in higher concentrations in humans [265] , future studies should determine if cisand trans-RSV would evoke distinct physiological outcomes in various experimental paradigms. 

Conflict of interest The authors declare that they have no conflict of interest. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. P Natl Acad Sci USA. Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial. Dig Liver Dis.

Occurrence of resveratrol and pterostilbene in age-old Drakshasava, an ayurvedic medicine from India

Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine (review)

Wine, alcohol, platelets, and the French paradox for coronary heart disease

Plant foods and herbal sources of resveratrol

Production of resveratrol by Vitis-Vinifera and other members of Vitaceae as a response to infection or injury

The production of resveratrol (3,5,4′-Trihydroxystilbene) by grape berries in different developmental stages

Production of the phytoalexin resveratrol by grapes as a response to Botrytis attack under natural conditions

Resveratrol, a new phenolic compound, from Veratrum grandiflorum

Therapeutic potential of resveratrol: the in vivo evidence

Resveratrol role in autoimmune disease-a mini-review

No beneficial effects of resveratrol on the metabolic syndrome: a randomized placebo-controlled clinical trial

What is new for an old molecule? Systematic review and recommendations on the use of resveratrol

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

A role for SIR-2.1 regulation of ER stress response genes in determining C-elegans life span

Resveratrol prolongs lifespan and retards the onset of age-related markers in a shortlived vertebrate

Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy

Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans

During yeast chronological aging resveratrol supplementation results in a short-lived phenotype Sir2-dependent

Resveratrol induces mitochondrial dysfunction and decreases chronological life span of Saccharomyces cerevisiae in a glucose-dependent manner

Two-carbon metabolites, polyphenols and vitamins influence yeast chronological life span in winemaking conditions

Substrate-specific activation of sirtuins by resveratrol

Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span

Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase

Resveratrol inhibits IL-33-mediated mast cell activation by targeting the MK2/3-PI3K/Akt axis

Enhancement of NF-kappaB activity by resveratrol in cytokine-exposed mesangial cells

Upregulation of FcgammaRIIB by resveratrol via NF-kappaB activation reduces B-cell numbers and ameliorates lupus

Resveratrol induces nuclear factor-kappaB activity in human cardiac cells

Resveratrol ameliorates atherosclerosis induced by highfat diet and LPS in ApoE(-/-) mice and inhibits the activation of CD4(+) T cells

Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice

Dual effects of resveratrol on arterial damage induced by insulin resistance in aged mice

Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway

Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3 beta inhibition downstream of poly(ADP-ribose)polymerase-LKB1 pathway

Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials

Usefulness of resveratrol supplementation in decreasing cardiometabolic risk factors comparing subjects with metabolic syndrome and healthy subjects with or without obesity: metaanalysis using multinational, randomised, controlled trials

The effects of resveratrol in patients with cardiovascular disease and heart failure: a narrative review

The effects of resveratrol on lipid profiles and liver enzymes in patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials

Resveratrol: twenty years of growth, development and controversy

Resveratrol commonly displays hormesis: occurrence and biomedical significance

Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework

Resveratrol induces DNA double-strand breaks through human topoisomerase II interaction

Resveratrol as a Pan-HDAC inhibitor alters the acetylation status of jistone proteins in human-derived hepatoblastoma cells

Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining

HDAC1 modulates OGG1-initiated oxidative DNA damage repair in the aging brain and Alzheimer's disease

HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP-43 proteinopathies

Resveratrol modulates DNA double-strand break repair pathways in an ATM/ATR-p53-and -Nbs1-dependent manner

Resveratrol selectively induces DNA damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma

Resveratrol induces downregulation of DNA repair genes in MCF-7 human breast cancer cells

Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells

Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast tumour cell lines

Resveratrol inhibits the growth and induces the apoptosis of both s

Cytometric analysis of cytotoxicity of polyphenols and related phenolics to rat thymocytes: potent cytotoxicity of resveratrol to normal cells

Resveratrol exerts dosage and duration dependent effect on human mesenchymal stem cell development

Resveratrol exerts dosage-dependent effects on the selfrenewal and neural differentiation of hUC-MSCs

Differential responses of transresveratrol on proliferation of neural progenitor cells and aged rat hippocampal neurogenesis

High doses of synthetic antioxidants induce premature senescence in cultivated mesenchymal stem cells

Resveratrol arrests the cell division cycle at S/G2 phase transition

Resveratrol inhibits extranodal NK/T cell lymphoma through activation of DNA damage response pathway

Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice

Comparative mitochondrialbased protective effects of resveratrol and nicotinamide in Huntington's disease models

Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease

Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons

Ligand-binding dynamics rewire cellular signaling via estrogen receptor-alpha

Nicotinamide augments the antiinflammatory properties of resveratrol through PARP1 activation

Estrogenic/antiestrogenic and scavenging properties of (E)-and (Z)-resveratrol

Effect of estradiol, diethylstilbestrol, and resveratrol on F0F1-ATPase activity from mitochondrial preparations of rat heart, liver, and brain

Dosis Facit Sanitatem-concentration-dependent effects of resveratrol on mitochondria

The impact of resveratrol and hydrogen peroxide on muscle cell plasticity shows a dosedependent interaction

Concentration-dependent effects of resveratrol and metabolites on the redox status of human erythrocytes in single-dose studies

Resveratrol inhibits drug-induced apoptosis in human leukemia cells by creating an intracellular milieu nonpermissive for death execution

Pro-ulcer effects of resveratrol in mice with indomethacin-induced gastric ulcers are reversed by L-arginine

Resveratrol exerts dose-dependent anti-fibrotic or profibrotic effects in kidneys: a potential risk to individuals with impaired kidney function

Resveratrol induces pro-oxidant effects and time-dependent resistance to cytotoxicity in activated hepatic stellate cells

Resveratrol inhibits cell growth by inducing cell cycle arrest in activated hepatic stellate cells

Resveratrol inhibits insulin responses in a SirT1-independent pathway

Resveratrol inhibits lipogenesis of 3T3-L1 and SGBS cells by inhibition of insulin signaling and mitochondrial mass increase

Resveratrol improves insulin signaling in a tissuespecific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents

Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet

Resveratrol: from diet to topical usage

Pre-formulation studies of resveratrol

Bioavailability and safety study of resveratrol 500 mg tablets in healthy male and female volunteers

Tissue distribution of trans-resveratrol and its metabolites after oral administration in human eyes

Endothelial cells deconjugate resveratrol metabolites to free resveratrol: a possible role in tissue factor modulation

Resveratrol and cellular mechanisms of cancer prevention

Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis

A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice

Resveratrol: one molecule, many targets

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity

Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases

AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol

SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1

Resveratrol is not a direct activator of SIRT1 enzyme activity

Mechanism of human SIRT1 activation by resveratrol

SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function

Evidence for a common mechanism of SIRT1 regul ation by all ost eric activators. Sci ence

Small-molecule allosteric activators of sirtuins

Impact of sirtuin-1 expression on H3K56 acetylation and oxidative stress: a double-blind randomized controlled trial with resveratrol supplementation

SIRT1 controls endothelial angiogenic functions during vascular growth

Impairment of an endothelial NAD(+)-H2S signaling network is a reversible cause of vascular aging. Cell

The suppressive effect of resveratrol on HIF-1alpha and VEGF expression after warm ischemia and reperfusion in rat liver

Resveratrol inhibits VEGF expression of human hepatocellular carcinoma cells through a NF-kappa-B mediated mechanism

Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPKmediated regulation of Nampt

Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state

The deacetylase enzyme SIRT1 is not associated with oxidative capacity in rat heart and skeletal muscle and its overexpression reduces mitochondrial biogenesis

SIRT1 gain of function does not mimic or enhance the adaptations to intermittent fasting

Resveratrol promotes myogenesis and hypertrophy in murine myoblasts

Resveratrol initiates differentiation of mouse skeletal muscle-derived C2C12 myoblasts

Resveratrol prevents the wasting disorders of mechanical unloading by acting as a physical exercise mimetic in the rat

When is Sirt1 activity bad for dying neurons?

SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons

Sirt1 contributes critically to the redox-dependent fate of neural progenitors

Resveratrol protects neurons and the myocardium by reducing oxidative stress and ameliorating mitochondria damage in a cerebral ischemia rat model

Resveratrol protects DAergic PC12 cells from high glucose-induced oxidative stress and apoptosis: effect on p53 and GRP75 localization

Resveratrol enhances neuroplastic changes, including hippocampal neurogenesis, and memory in Balb/C mice at six months of age

Resveratrol counteracts lipopolysaccharide-induced depressive-like behaviors via enhanced hippocampal neurogenesis

Mitochondrial dynamics in postmitotic cells regulate neurogenesis

Resveratrol attenuates oxidative injury in human umbilical vein endothelial cells through regulating mitochondrial fusion via TyrRS-PARP1 pathway

SIRT1 activates MAO-A in the brain to mediate anxiety and exploratory drive

Resveratrol suppresses neuroinflammation in the experimental paradigm of autism spectrum disorders

Resveratrol improves Neuroimmune dysregulation through the inhibition of neuronal toll-like receptors and COX-2 signaling in BTBR T+ Itpr3(tf)/J mice

Resveratrol attenuates pro-inflammatory cytokines and activation of JAK1-STAT3 in BTBR T(+) Itpr3(tf)/J autistic mice

Resveratrol ameliorates dysregulation of Th1, Th2, Th17, and T regulatory cellrelated transcription factor signaling in a BTBR T + tf/J mouse model of autism

Inhibition of xanthine and monoamine oxidases by stilbenoids from Veratrum taliense

Inhibitory effects of cis-and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity

Novel targets for Huntington's disease in an mTOR-independent autophagy pathway

Resveratrol alleviates motor and cognitive deficits and neuropathology in the A53T alpha-synuclein mouse model of Parkinson's disease

A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease

Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease

SIRT2 inhibition improves functional motor recovery after peripheral nerve injury

hSIR2(SIRT1) functions as an NADdependent p53 deacetylase

Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway

Acetylation is indispensable for p53 antiviral activity

Resveratrol promotes nerve regeneration via activation of p300 acetyltransferase-mediated VEGF signaling in a rat model of sciatic nerve crush injury

Resveratrol stimulates AMP kinase activity in neurons

Cell metabolism. The resurgence of NAD(+)

Direct gas-chromatographic mass-spectrometric method to assay Cis-resveratrol in wines -preliminary survey of its concentration in commercial wines

Determination of trans-and cis-resveratrol in Serbian commercial wines

Levels of cis-and trans-resveratrol and their glucosides in white and rose Vitis vinifera wines from Spain

cis-Resveratrol produces anti-inflammatory effects by inhibiting canonical and non-canonical inflammasomes in macrophages

Effects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genes

Effect of cis-resveratrol on genes involved in nuclear factor kappa B signaling

Anti-tumor properties of cis-resveratrol methylated analogs in metastatic mouse melanoma cells

Antineoplastic agents. 465. Structural modification of resveratrol: Sodium resverastatin phosphate

Trans-and cisresveratrol increase cytoplasmic calcium levels in A7r5 vascular smooth muscle cells

Effects of trans-and cis-resveratrol on Ca2+ handling in A7r5 vascular myocytes

Trans-but not Cisresveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-kappa B activation and peroxisome proliferator-activated receptor-gamma upregulation

Antiplatelet activity of cis-resveratrol

A comparative study of the anti-platelet effects of cis-and trans-resveratrol

Comparative studies of the antioxidant effects of cis-and trans-resveratrol

Regioselective and stereospecific glucuronidation of trans-and cis-resveratrol in human

Resveratrol is efficiently glucuronidated by UDP-glucuronosyltransferases in the human gastrointestinal tract and in Caco-2 cells

Cis-resveratrol glucuronidation kinetics in human and recombinant UGT1A sources

HPLCtandem mass spectrometric method to characterize resveratrol metabolism in humans

cis-and trans-resveratrol are glucuronidated in rat brain, olfactory mucosa and cultured astrocytes

Aminoacyl-tRNA synthesis

Essential nontranslational functions of tRNA synthetases

Survival from hypoxia in C-elegans by inactivation of aminoacyl-tRNA Synthetases

Methionyl-tRNA synthetase regulates lifespan in Drosophila

New functions of aminoacyl-tRNA synthetases beyond translation

Trp-tRNA synthetase bridges DNA-PKcs to PARP-1 to link IFN-gamma and p53 signaling

Human tRNA synthetase catalytic nulls with diverse functions

Metabolite profiles and the risk of developing diabetes

Diabetes risk and amino acid profiles: crosssectional and prospective analyses of ethnicity, amino acids and diabetes in a South Asian and European cohort from the SABRE (Southall and Brent REvisited) study

Tyrosine is associated with insulin resistance in longitudinal metabolomic profiling of obese children

An individual participant data metaanalysis on metabolomics profiles for obesity and insulin resistance in European children

An amino acid signature associated with obesity predicts 2-year risk of hypertriglyceridemia in school-age children

Plasma tyrosine and its interaction with low high-density lipoprotein cholesterol and the risk of type 2 diabetes mellitus in Chinese

A branched-chain amino acid-related metabolic signature that differentiates obese and Lean humans and contributes to insulin resistance

Plasma amino acid levels and insulin secretion in obesity

Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease

Serum amino acid profiles and their alterations in colorectal cancer

Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development

A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol

Mechanism of inhibition of bovine F-1-ATPase by resveratrol and related polyphenols

Crystal structures of Sirt3 complexes with 4′-bromo-resveratrol reveal binding sites and inhibition mechanism

Pleiotropic mechanisms facilitated by resveratrol and its metabolites

Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy

A novel multisystem disease associated with recessive mutations in the tyrosyl-tRNA synthetase (YARS) gene

Homozygosity for a mutation affecting the catalytic domain of tyrosyl-tRNA synthetase (YARS) causes multisystem disease

An expanded multi-organ disease phenotype associated with mutations in YARS

Alternative stable conformation capable of protein misinteraction links tRNA synthetase to peripheral neuropathy

tRNA-controlled nuclear import of a human tRNA synthetase

Oxidative stress diverts tRNA synthetase to nucleus for protection against DNA damage

Acetylation promotes TyrRS nuclear translocation to prevent oxidative damage

Moonlighting matrix metalloproteinase substrates: enhancement of proinflammatory functions of extracellular tyrosyl-tRNA synthetase upon cleavage

Resveratrol improves delayed r-tPA treatment outcome by reducing MMPs

Resveratrol inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible neuroprotection

Nonspecific binding of RNA to PARP1 and PARP2 does not Lead to catalytic activation

The multifaceted roles of PARP1 in DNA repair and chromatin remodelling

ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate

ADP-ribose) polymerase-1 antagonizes DNA resection at double-strand breaks

Role of poly(ADP-ribose) formation in DNA repair

Bridging of DNA breaks activates PARP2-HPF1 to modify chromatin

Extracellular NAD(+) enhances PARPdependent DNA repair capacity independently of CD73 activity

A ketogenic diet extends longevity and Healthspan in adult mice

HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation

Structural basis for allosteric PARP-1 retention on DNA breaks

Structural basis for DNA damage-dependent poly(ADP-ribosyl)ation by human PARP-1

Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation

Requirement of poly(ADPribose) polymerase in recovery from DNA damage in mice and in cells

ADP-ribose) polymerase-1 is a survival factor for radiation-exposed intestinal epithelial stem cells in vivo

Poly(ADP-ribose) polymerase 1 escorts XPC to UVinduced DNA lesions during nucleotide excision repair

Kinetics of poly(ADP-ribosyl)ation, but not PARP1 itself, determines the cell fate in response to DNA damage in vitro and in vivo

PARP-1-dependent recruitment of cold-inducible RNA-binding protein promotes double-strand break repair and genome stability

PARP1 and PARP2 stabilise replication forks at base excision repair intermediates through Fbh1-dependent Rad51 regulation

ADP-ribose-derived nuclear ATP synthesis by NUDIX5 is required for chromatin remodeling

PARP-1/PARP-2 double deficiency in mouse T cells results in faulty immune responses and T lymphomas

ADP-ribosyl-acceptor hydrolase 3 regulates poly (ADP-ribose) degradation and cell death during oxidative stress

ADP-ribosyl)ation regulates CTCF-dependent chromatin insulation

PARP1-and CTCF-mediated interactions between active and repressed chromatin at the lamina promote oscillating transcription

ADP-ribose) polymerase 1 participates in the phase entrainment of circadian clocks to feeding

NAD+-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1

Dopamine triggers CTCFdependent morphological and genomic remodeling of astrocytes

The NAD(+)/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling

High speed of fork progression induces DNA replication stress and genomic instability

PARP1 protects from benzo[a]pyrene diol epoxide-induced replication stress and mutagenicity

Long-term memory requires polyADP-ribosylation

Histone H1 poly[ADP]-ribosylation regulates the chromatin alterations required for learning consolidation

PARP-1 activity is required for the reconsolidation and extinction of contextual fear memory

PolyADP-ribosylation is required for long-term memory formation in mammals

KIF4 motor regulates activity-dependent neuronal survival by suppressing PARP-1 enzymatic activity

ADP-ribose) polymerase-1 protects neurons against apoptosis induced by oxidative stress

Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation

Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2

Activating the PARP-1 sensor component of the groucho/ TLE1 corepressor complex mediates a CaMKinase IIdelta-dependent neurogenic gene activation pathway

PARP-1 deletion promotes subventricular zone neural stem cells toward a glial fate

PARP1 deficiency exacerbates diet-induced obesity in mice

Defective neurogenesis and schizophrenia-like behavior in PARP-1-deficient mice

NGF promotes long-term memory formation by activating poly(ADP-ribose)polymerase-1

DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation

NAD(+) depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death

Nerve growth factor and forskolin prevent H2O2-induced apoptosis in PC12 cells by glutathione independent mechanism

Free radical-independent protection by nerve growth factor and Bcl-2 of PC12 cells from hydrogen peroxide-triggered apoptosis

Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones

Chromatin repair after oxidative stress: role of PARP-mediated proteasome activation

ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission

Nucleolar PARP-1 Expression is decreased in Alzheimer's disease: consequences for epigenetic regulation of rDNA and cognition

The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression

Regulation of glucose metabolism by NAD(+) and ADP-ribosylation

ADP-ribose) polymerase activity in mononuclear leukocytes of 13 mammalian species correlates with species-specific life span

Increased poly(ADP-ribose) polymerase activity in lymphoblastoid cell lines from centenarians

Naked mole rat cells display more efficient excision repair than mouse cells

Amyloid beta and the longestlived rodent: the naked mole-rat as a model for natural protection from Alzheimer's disease

PARP inhibitors in clinical use induce genomic instability in normal human cells

PARP1 trapping by PARP inhibitors drives cytotoxicity in both cancer cells and healthy bone marrow

ADP-ribose) polymerase-1 is a nuclear epigenetic regulator of mitochondrial DNA repair and transcription

LPS protects macrophages from AIF-independent parthanatos by downregulation of PARP1 expression, induction of SOD2 expression, and a metabolic shift to aerobic glycolysis. Free Radic Biol Med. 2 0 1 9

ARTD1/PARP1 negatively regulates glycolysis by inhibiting hexokinase 1 independent of NAD+ depletion

ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis

Nuclear cGAS suppresses DNA repair and promotes tumorigenesis

Cutting edge: proteolytic inactivation of poly(ADPribose) polymerase 1 by the Nlrp3 and Nlrc4 inflammasomes

PARP1 depletion induces RIG-I-dependent signaling in human cancer cells

Defective DNA single-strand break repair is responsible for senescence and neoplastic escape of epithelial cells

ADP-ribose) polymerase-1 depletion enhances the severity of inflammation in an imiquimodinduced model of psoriasis

Restriction of AID activity and somatic hypermutation by PARP-1

PARP-1 deficiency increases the severity of disease in a mouse model of multiple sclerosis

Deficiency in poly(ADP-ribose) polymerase-1 (PARP-1) accelerates aging and spontaneous carcinogenesis in mice

PARP inhibitor efficacy depends on CD8(+) T-cell recruitment via intratumoral STING pathway activation in BRCA-deficient models of triplenegative breast cancer. Cancer Discov

PARP inhibition elicits STING-dependent antitumor immunity in Brca1-deficient ovarian

Activation of STING-dependent innate immune signaling by S-phase-specific DNA damage in breast cancer

Differential regulation of breast cancer bone metastasis by PARP1 and PARP2

PARP1 suppresses the transcription of PD-L1 by poly(ADP-Ribosyl)ating STAT3

Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action

XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia

ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia

Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss

Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor

Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity

ADPribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism

NMDA but not non-NMDA excitotoxicity is mediated by poly(ADP-ribose) polymerase

Daily rhythm in tyrosine concentration in human plasma: persistence on low-protein diets

Daily rhythms in the concentrations of various amino acids in human plasma

The relationship of human growth hormone and plasma tyrosine during sleep

Daily rhythms in content and utilization of tyrosine in the whole mouse

Mechanism of the daily rhythm in hepatic tyrosine transaminase activity: role of dietary tryptophan

Induction of hepatic tyrosine aminotransferase mediated by a cholinergic agent

Central neural regulation by adrenergic nerves of the daily rhythm in hepatic tyrosine transaminase activity

Effect of resveratrol and some other natural compounds on tyrosine kinase activity and on cytolysis

Resveratrol restores the circadian rhythmic disorder of lipid metabolism induced by high-fat diet in mice

Resveratrol regulates circadian clock genes in Rat-1 fibroblast cells

caffeic acid and resveratrol regulate circadian clock genes and aging-related genes in young and old human lung fibroblast cells

Rhythmic histone acetylation underlies transcription in the mammalian circadian clock

Resveratrol opposite effects on rat tissue lipoperoxidation: pro-oxidant during day-time and antioxidant at night

Effects of dietary resveratrol on the sleepwake cycle in the non-human primate gray mouse lemur (Microcebus murinus)

Resveratrol dietary supplementation shortens the free-running circadian period and decreases body temperature in a prosimian primate

Nocturnal resveratrol administration inhibits chemically induced breast cancer formation in rats

Potential circadian effects on translational failure for neuroprotection

Longitudinal plasma metabolomics of aging and sex

Ageing investigation using two-time-point metabolomics data from KORA and CARLA studies

Effect of caloric restriction on BMI, gut microbiota, and blood amino acid levels in non-obese adults

Weight-loss diets and 2-y changes in circulating amino acids in 2 randomized intervention trials

Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients

Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis

A diabetes-predictive amino acid score and future cardiovascular disease

TATN-1 mutations reveal a novel role for tyrosine as a metabolic signal that influences developmental decisions and longevity in Caenorhabditis elegans

Tyrosine aminotransferase is involved in the oxidative stress response by metabolizing meta-tyrosine in Caenorhabditis elegans

Tyrosine administration decreases glutathione and stimulates lipid and protein oxidation in rat cerebral cortex

Effect of acute administration of L-tyrosine on oxidative stress parameters in brain of young rats

L-tyrosine induces DNA damage in brain and blood of rats

Role of antioxidant treatment on DNA and lipid damage in the brain of rats subjected to a chemically induced chronic model of tyrosinemia type II

Antioxidants reverse the changes in energy metabolism of rat brain after chronic administration of L.-tyrosine. Metab Brain Dis

The characterization of neuroenergetic effects of chronic L-tyrosine administration in young rats: evidence for striatal susceptibility

A role for foregut tyrosine metabolism in glucose tolerance

Tyrosine detoxification is an essential trait in the life history of blood-feeding arthropods

Developmental roles of tyrosine metabolism enzymes in the blood-sucking insect Rhodnius prolixus

The effects of graded levels of calorie restriction: XIII. Global Metabolomics Screen Reveals Graded Changes in Circulating Amino Acids, Vitamins, and Bile Acids in the Plasma of C57BL/6 Mice

Dopamine D1/D5 receptor signaling regulates synaptic cooperation and competition in hippocampal CA1 pyramidal neurons via sustained ERK1/2 activation

Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death

Acute administration of branched-chain amino acids increases the pro-BDNF/total-BDNF ratio in the rat brain

An evaluation of the effects of acute and chronic L-tyrosine administration on BDNF levels and BDNF mRNA expression in the rat brain

Dosedependent effects of oral tyrosine administration on plasma tyrosine levels and cognition in aging

Tyrosine-and phenylalaninerestricted formula diet augments immunocompetence in healthy humans

Antiatherogenic effect of resveratrol attributed to decreased expression of ICAM-1 (intercellular adhesion molecule-1)

Resveratrol induces apoptosis in human melanoma cell through negatively regulating Erk/PKM2/Bcl-2 axis

Resveratrol suppresses melanoma growth by promoting autophagy through inhibiting the PI3K/AKT/mTOR signaling pathway

Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbidopa-levodopa methyl ester chemotherapy

Tumor response to phenylalanine-tyrosine-limited diets

Effects of reducing the phenylalaninetyrosine intake of patients with advanced malignant melanoma

Focal adhesion kinase-dependent apoptosis of melanoma induced by tyrosine and phenylalanine deficiency

Resveratrol targets TyrRS acetylation to protect against radiationinduced damage

Discovery of human TyrRS inhibitors by structurebased virtual screening, structural optimization, and bioassays

Resveratrol's hidden hand: a route to the optical detection of biomolecular binding

Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations